CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2-Reference-Cited by-同舟云学术

CUDC‑907 reverses pathological phenotype of keloid fibroblasts in vitro and in vivo via dual inhibition of PI3K/Akt/mTOR signaling and HDAC2

Published:2019-09-23 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Tu Tian¹,Huang Jia¹,Lin Miaomiao²,Gao Zhen¹,Wu Xiaoli¹,Zhang Wenjie¹,Zhou Guangdong¹,Wang Wenbo¹,Liu Wei¹

Affiliation:

1. Department of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, P.R. China

2. Department of Otolaryngology, Suzhou First People's Hospital, Suzhou, Anhui 234000, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural products - Dawn of keloid treatment;Fitoterapia;2024-06

2. Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa;British Journal of Dermatology;2024-05-31

3. Diagnosis and management in Rubinstein-Taybi syndrome: first international consensus statement;Journal of Medical Genetics;2024-03-12

4. Multifaceted approach toward mapping out the anticancer properties of small molecules via in vitro evaluation on melanoma and nonmelanoma skin cancer cells, and in silico target fishing;Chemical Biology & Drug Design;2023-12-15

5. Low-Intensity Nanosecond Pulsed Electric Field Accelerates Osteogenic Transformation of Human Dermal Fibroblasts by Enhancing Cell Pluripotency;Cellular Reprogramming;2023-12-01